2019
DOI: 10.1016/j.bioorg.2019.103307
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
32
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 69 publications
(32 citation statements)
references
References 30 publications
0
32
0
Order By: Relevance
“…Scientists are more interested in estimating the drug-likeness properties that are bioavailability, pharmacokinetics (how body responds to the drug), pharmacodynamics (how drug acts on the body), solubility, toxicity, lipophilicity, permeability, logP, logD, kinetic and thermodynamic solubility, the volume of distribution, and biotransformation [24]. The underlying goal and end-game for all ADME studies are to better understand a compound's metabolite-mediated toxicity and safety profile to make a concrete decision on whether the compound can progress to late-stage preclinical and clinical studies to enable filing for an investigational new drug, new drug agreement, or a biologics licensing agreement.…”
Section: Discussionmentioning
confidence: 99%
“…Scientists are more interested in estimating the drug-likeness properties that are bioavailability, pharmacokinetics (how body responds to the drug), pharmacodynamics (how drug acts on the body), solubility, toxicity, lipophilicity, permeability, logP, logD, kinetic and thermodynamic solubility, the volume of distribution, and biotransformation [24]. The underlying goal and end-game for all ADME studies are to better understand a compound's metabolite-mediated toxicity and safety profile to make a concrete decision on whether the compound can progress to late-stage preclinical and clinical studies to enable filing for an investigational new drug, new drug agreement, or a biologics licensing agreement.…”
Section: Discussionmentioning
confidence: 99%
“…[13] Pogaku and coworkers synthesized new derivatives of triazolopyrimidine, which revealed α-glucosidase inhibitor activity. [14] In addition, the presence of fluoride atom on the skeleton of heterocyclic drugs improves their activity. [15,16] Recently, the widespread of COVID-19, caused by the new coronavirus 2 (SARS-CoV-2), all over the world has emerged as a serious concern to public health.…”
Section: Introductionmentioning
confidence: 99%
“…Due to the sugar-based structure of mentioned α-glucosidase inhibitors, their synthesis needs complicated multistep procedures 6 . Unfortunately, administration of these inhibitors is associated with undesirable side effects including diarrhea, abdominal discomfort, and atulence 7,8 . Thus, it would be essential to develop novel, safe, and e cient α-glucosidase inhibitors as an effective lead candidate for future antidiabetic drug discovery initiatives.…”
Section: Introductionmentioning
confidence: 99%